A detailed history of Teacher Retirement System Of Texas transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 37,271 shares of NUVB stock, worth $107,713. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,271
Previous 29,672 25.61%
Holding current value
$107,713
Previous $87,000 2.3%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.3 - $3.83 $17,477 - $29,104
7,599 Added 25.61%
37,271 $85,000
Q2 2024

Aug 09, 2024

BUY
$2.58 - $3.69 $76,553 - $109,489
29,672 New
29,672 $87,000
Q3 2023

Oct 31, 2023

BUY
$1.26 - $2.1 $2,080 - $3,467
1,651 Added 5.08%
34,151 $46,000
Q2 2023

Jul 19, 2023

SELL
$1.56 - $1.84 $6,761 - $7,974
-4,334 Reduced 11.77%
32,500 $59,000
Q1 2023

May 12, 2023

BUY
$1.6 - $2.48 $37,688 - $58,416
23,555 Added 177.39%
36,834 $61,000
Q4 2022

Feb 10, 2023

SELL
$1.68 - $2.5 $6,288 - $9,357
-3,743 Reduced 21.99%
13,279 $25,000
Q3 2022

Nov 03, 2022

BUY
$0.29 - $4.04 $40 - $565
140 Added 0.83%
17,022 $38,000
Q2 2022

Aug 09, 2022

SELL
$3.24 - $5.85 $18,487 - $33,380
-5,706 Reduced 25.26%
16,882 $55,000
Q1 2022

May 09, 2022

BUY
$4.6 - $8.83 $9,379 - $18,004
2,039 Added 9.92%
22,588 $119,000
Q4 2021

Feb 10, 2022

BUY
$7.75 - $10.05 $10,323 - $13,386
1,332 Added 6.93%
20,549 $175,000
Q3 2021

Nov 09, 2021

BUY
$7.78 - $10.0 $28,879 - $37,120
3,712 Added 23.94%
19,217 $191,000
Q2 2021

Aug 05, 2021

BUY
$9.22 - $14.48 $142,956 - $224,512
15,505 New
15,505 $144,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $628M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.